Semax 10mg | UK Stock | Research Peptide

Semax Research Peptide 10mg — UK Stock

Semax is a synthetic heptapeptide research compound studied in laboratory and analytical research for its relationship to adrenocorticotropic hormone fragment ACTH(4-10). It is widely referenced in peptide research relating to melanocortin signalling, ACTH fragment analysis, regulatory peptide studies, and analytical peptide characterisation.

Semax is a modified ACTH-derived peptide with the amino acid sequence Met-Glu-His-Phe-Pro-Gly-Pro, also written as MEHFPGP. It is of interest in laboratory research involving short synthetic peptides, peptide stability, receptor-related signalling pathways, and bioactive peptide analysis.

This Semax 10mg research peptide is held in UK stock and supplied for laboratory, analytical, and research use only. UK-based availability allows suitable research customers to source Semax research material with domestic dispatch and secure packaging.

Chemical Information:
Product Name: Semax
Common Names: Semax, ACTH(4-10) analog, ACTH4-7-PGP
CAS Number: 80714-61-0
Molecular Formula: C37H51N9O10S
Molecular Weight: 813.93 Da
Sequence: Met-Glu-His-Phe-Pro-Gly-Pro
Short Sequence: MEHFPGP
Peptide Type: Synthetic heptapeptide
Sequence Length: 7 amino acids
Research Category: ACTH-derived peptide / regulatory peptide research compound
Stock Location: UK stock
Use: Laboratory and analytical research only

This product is supplied strictly for laboratory, analytical, and research purposes only. It is not intended for human consumption, medical use, diagnostic use, therapeutic use, cosmetic use, veterinary use, or any form of personal use.

For research use only.